Breakdown value imported drugs Japan 2021, by category
In 2021, antineoplastic drugs, which are not included in other classification, accounted for close to 20 percent of the total pharmaceutical drug imports value in Japan. Other metabolism affecting agents followed with about 10.8 percent of the drug imports value.